日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of fremanezumab on migraine-associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double-blind, placebo-controlled trial

fremanezumab 对日本和韩国发作性偏头痛患者的偏头痛相关症状和药物使用情况的影响:一项多中心、随机、双盲、安慰剂对照试验的探索性终点分析

Tatsumoto, Muneto; Ishida, Miki; Iba, Katsuhiro; Kim, Byung-Kun; Ning, Xiaoping; Osawa, Chihiro; Nakai, Masami; Kurita, Yuka

A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation

迟发性运动障碍药物靶点VMAT-2参与神经元突起的延伸

Ishida, Miki; Ichikawa, Ryuya; Ohbuchi, Katsuya; Oizumi, Hiroaki; Miyamoto, Yuki; Yamauchi, Junji

Prevalence of Antibodies to Japanese Encephalitis Virus and Severe Fever with Thrombocytopenia Syndrome Virus in Wild Boars Captured Across Different Locations in Toyama Prefecture, Japan

日本富山县不同地区捕获的野猪体内日本脑炎病毒和发热伴血小板减少综合征病毒抗体的流行情况

Yazawa, Shunsuke; Yoshida, Kotoha; Fujii, Kotaro; Saga, Yumiko; Taniguchi, Sara; Suzuki, Ryosuke; Lim, Chang-Kweng; Ishida, Miki; Oishi, Kazunori; Tani, Hideki

Hypomyelination Leukodystrophy 16 (HLD16)-Associated Mutation p.Asp252Asn of TMEM106B Blunts Cell Morphological Differentiation.

髓鞘形成不足性脑白质营养不良 16 (HLD16) 相关突变 TMEM106B 的 p.Asp252Asn 会抑制细胞形态分化

Sawaguchi Sui, Ishida Miki, Miyamoto Yuki, Yamauchi Junji

Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

弗瑞马珠单抗对日本慢性偏头痛患者药物过度使用的影响:一项多中心、随机、双盲、安慰剂对照试验的事后分析

Imai, Noboru; Isogai, Yuki; Shibasaki, Yoshiyuki; Nakai, Masami; Ishida, Miki; Ning, Xiaoping; Koga, Nobuyuki

Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

弗瑞马珠单抗用于日本患者慢性偏头痛预防:两项国际试验的亚组分析

Saigoh, Kazumasa; Takeshima, Takao; Nakai, Masami; Shibasaki, Yoshiyuki; Ishida, Miki; Ning, Xiaoping; Barash, Steve; Isogai, Yuki; Koga, Nobuyuki

Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

弗瑞马珠单抗用于预防日本患者发作性偏头痛:两项国际试验的亚组分析

Saigoh, Kazumasa; Takeshima, Takao; Nakai, Masami; Shibasaki, Yoshiyuki; Ishida, Miki; Ning, Xiaoping; Barash, Steve; Isogai, Yuki; Koga, Nobuyuki

Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients

fremanezumab治疗发作性及慢性偏头痛患者的早期疗效:两项针对日本和韩国患者的2b/3期临床试验的亚组分析

Takeshima, Takao; Nakai, Masami; Shibasaki, Yoshiyuki; Ishida, Miki; Kim, Byung-Kun; Ning, Xiaoping; Koga, Nobuyuki

Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study

弗瑞马珠单抗用于日本门诊偏头痛预防治疗的长期安全性和耐受性:一项多中心、随机、开放标签研究

Sakai, Fumihiko; Suzuki, Norihiro; Ning, Xiaoping; Ishida, Miki; Usuki, Chiharu; Iba, Katsuhiro; Isogai, Yuki; Koga, Nobuyuki